Endometriosis

A Clinical Research Study For Pain Associated with Endometriosis

If you experience moderate-to-severe pain caused by endometriosis and have had a surgical diagnosis for your endometriosis, learn more about the elaris EM-COC Study. The elaris EM-COC Study is evaluating whether the study medication, when taken together with an approved birth control pill, may reduce moderate-to-severe endometriosis pain.

Clinical Research Partners (7110 Forest Avenue, Suite 201, Richmond, VA 23226)
Summary

The purpose of this Study is to evaluate whether the study medication, when taken together with an approved birth control pill, may reduce moderate-to-severe endometriosis pain.

Age

18-49

Exclusions

  • Have had a diagnosis of endometriosis
  • Experience moderate-to-severe endometriosis pain
  • Are not pregnant or actively trying to get pregnant, or breastfeeding
  • Are a non smoker (if 33 years or older)

Compensation

  • You may compensated up to $2,325 for participation.

Meet Our Team

Our experienced team will guide you through the process

Dr. Call, co-founder of Clinical Research Partners, serves as President. He is a Certified Principle Investigator

Robert S. Call, MD, CPI

President

Annette Bennett, co-founder of Clinical Research Partners, serves as Chief Executive Officer and Research Director. She

Annette Bennett

Chief Executive Officer

Bo Vaughan is a native of Richmond, VA and forward-thinking health care strategist with a

Bo Vaughan, MD, MSHA, CPI

Medical Director

Jeanette Weller

EVP of Contracts and Budgets

Caitlin Vining

Controller CCRP

Kelly Craighead, BS, RN, CCRC

Regulatory Affairs Director

Carly McLaughlin, PharmD

Director of Pharmacy PharmD

Chrissy Robinson

Director of Quality Control

Erica Glenn, CCMA,CCRC

Manager of Off-site New Studies